Our applied methodology research portfolio investigates best practice in trial design, conduct, analysis and reporting. We specialise in applied methodology research which allows exploration and ...

Our team of experienced statisticians, trial managers, data managers, clinical IT systems and administrative staff supports the full trial life cycle from initial discussions of trial concept, through ...

ATARI investigates whether a new type of drug could help treat people with certain types of gynaecological cancers that have come back after treatment. UK Co-ordinating Committee on Cancer Research ...

The ICR-CTSU manages a number of trials in different disease sites. Use the filter below to view trials for each cancer type: ATARI investigates whether a new type of drug could help treat people with ...

I have been at ICR for over 17 years, during which time I have worked on a number of small molecule targeting drug discovery projects. These have ranged from kinases, including AKT, to more recently ...

My research area of interest is early stage drug discovery. I have recently started working on the design and synthesis of new inhibitors of HSET in order to interrupt centrosome clustering in cancer ...

Professor Gail ter Haar leads the Therapeutic Ultrasound Team at the ICR. She is investigating the use of high intensity focused ultrasound (HIFU) for treating cancers in the brain and abdomen.

We are very grateful that so many of you recognise the cutting-edge research carried out at The Institute of Cancer Research, either by leaving a legacy in your Will or by funding our researchers to ...

Professor Kevin Harrington is Professor of Biological Cancer Therapies and Joint Head of the Division of Radiotherapy and Imaging at the ICR. He works at the forefront of research into biologically ...

The Institute of Cancer Research, London runs one of the most successful academic drug development programmes in the world, in close partnership with our partner hospital The Royal Marsden. The Drug ...